Sort
82,697 grants matching “vaccine development”
Systems-level identification of key regulators deciding immune cell state
$720,299Wei Wang · University Of California, San Diego · R01 · FY2022 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$720,290Shabaana A. Khader · Washington University · R01 · FY2021 · AI
Statistical Issues in AIDS Research
$720,231James P Hughes · University Of Washington · R37 · FY2023 · AI
Mucosal Helper-dependent Adenovirus Vaccines Against HIV
$720,202Michael A Barry · Mayo Clinic Rochester · R56 · FY2009 · AI
A cross protective multivalent vaccine for Shigella and ETEC
$720,111David A Sack · Johns Hopkins University · R01 · FY2025 · AI
Antigen export in M. tuberculosis evasion of CD4 T cells
$720,090Joel D. Ernst · New York University School Of Medicine · R01 · FY2017 · AI
Novel recombinant Rotavirus vaccine utilizing the probiotic microorganism Lactobacillus acidophilus
$720,054Gregg A Dean · Colorado State University · R01 · FY2024 · AI
Microbial ecology of the inflamed intestine
$719,973Brian M Ahmer · Ohio State University · R01 · FY2018 · AI
Defining immunological mechanisms of serovar cross-reactivity to develop broad spectrum protective vaccines for typhoidal and non-typhoidal Salmonella infections in humans
$719,928Marcelo B. Sztein · University Of Maryland Baltimore · U19 · FY2020 · AI
Mechanisms Underlying Persistent Lentivirus Replication in Follicular T Cells
$719,925Elizabeth Connick · University Of Arizona · R01 · FY2017 · AI
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$719,898Justin Richard Bailey · Johns Hopkins University · R01 · FY2018 · AI
Genetic Markers of Long-Term Mumps Vaccine Immunity
$719,830Richard B Kennedy · Mayo Clinic Rochester · R01 · FY2016 · AI
Regulation of CTCF Functions and Target Sites by Cancer/Testis-specific CTCF Like BORIS Factor
$719,820Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Primate Studies
$719,755James Gibson Else · Dana-Farber Cancer Inst · P01 · FY2008 · AI
HPV Vaccination, Attitudes and Sequential Behaviors in Adolescent Women
$719,752Marcia Lynne Shew · Indiana University Indianapolis · R56 · FY2009 · AI
Natural Resistance to Mycobacterium Tuberculosis Infection
$719,693W. Henry Henry Boom · Case Western Reserve University · U01 · FY2015 · AI
Development of a High-Throughput Microfluidics-Enabled Functional Assay for Rapidly Identifying Neutralizing Antibodies
$719,651Paul De Figueiredo · Texas A&M University · R01 · FY2020 · AI
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
$719,578Joshua K Lin · Brigham And Women'S Hospital · R01 · FY2022 · AG
Molecular and structural characterization of broadly neutralizing anti-HCV antibodies
$719,568Justin Richard Bailey · Johns Hopkins University · R01 · FY2019 · AI
Identification and analysis of compensatory mutations that support the evolution of antibiotic resistance in Neisseria gonorrhoeae
$719,533Yonatan H Grad · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2024 · AI
Salmonella-specific therapeutics
$719,497Brian M Ahmer · Ohio State University · R01 · FY2019 · AI
Non-canonical epitope presentation and antigen processing by MHC-E
$719,468Klaus J Frueh · Oregon Health & Science University · R01 · FY2023 · AI
Proteomics-Driven Reverse Vaccinology for Gonorrhea
$719,450Aleksandra Elzbieta Sikora · Oregon State University · R01 · FY2023 · AI
Novel Lymphocyte Chemoattractant Receptor and Ligand
$719,405Eugene C Butcher · Palo Alto Veterans Instit For Research · R01 · FY2024 · AI
EIAV Envelope Variation and Vaccine Efficacy
$719,298Ronald C Montelaro · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · AI